Boorsma, Eva M.
ter Maaten, Jozine M.
Damman, Kevin
Dinh, Wilfried
Gustafsson, Finn
Goldsmith, Steven
Burkhoff, Daniel
Zannad, Faiez http://orcid.org/0000-0001-7456-1570
Udelson, James E.
Voors, Adriaan A. http://orcid.org/0000-0002-5417-4415
Article History
Accepted: 2 April 2020
First Online: 15 May 2020
Competing interests
: W.D. reports full-time employment at Bayer. F.G. receives advisor fees from Abbott, Bayer, Carmat, Impulse Dynamics, Novartis and Pfizer and speaker fees from AstraZeneca, Boehringer Ingelheim and Orion Pharma. S.G. has received consultancy fees and/or research grants from Abbott Laboratories, Bayer and Otsuka Pharmaceuticals. J.E.U. reports research funding for trial activities from Bayer. A.A.V. has received consultancy fees and/or research grants from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Myokardia, Novartis and Roche Diagnostics. The other authors declare no competing interests.